ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres for treatment of liver tumors'

Prensa/medios de comunicación: Research

Períodoabr. 19 2022

Cobertura de los medios

1

Cobertura de los medios

  • NombreABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres for treatment of liver tumors'
    Nombre/canal del medio de comunicaciónMENAFN -Press Releases (English)
    País/TerritorioJordan
    Fecha4/19/22
    PersonasRobert Joseph Abraham